Gandeeva Therapeutics is using the power of cryo-EM and machine learning to advance drug discovery. Cryo-EM is a microscopy method that enables visualization of protein structures. Protein structures and their interactions are altered in almost all diseases. Using advances in resolution of cryo-EM in their platform, Gandeeva is imaging protein interfaces and using machine learning to develop precision medicines to treat challenging diseases. The Cryo-EM engine, HYPERFOCUS, enables mapping of druggable sites onto atomic resolution protein images. Gandeeva’s approach will tackle many targets from allosteric proteins, protein-protein complexes, nucleic acid protein complexes to membrane proteins using therapies ranging from small molecules to engineered antibodies.

<p>Gandeeva Therapeutics is using the power of cryo-EM and machine learning to advance drug discovery. Cryo-EM is a microscopy method that enables visualization of protein structures. Protein structures and their interactions are altered in almost all diseases. Using advances in resolution of cryo-EM in their platform, Gandeeva is imaging protein interfaces and using machine learning to develop precision medicines to treat challenging diseases. The Cryo-EM engine, HYPERFOCUS, enables mapping of druggable sites onto atomic resolution protein images. Gandeeva’s approach will tackle many targets from allosteric proteins, protein-protein complexes, nucleic acid protein complexes to membrane proteins using therapies ranging from small molecules to engineered antibodies.</p>


Gandeeva Therapeutics

Founded: 2021
Location: Vancouver, BC
Employee range: 11 - 50
Clinical stage: RD
Therapy area: Oncology
Drug types: ONC
Lead product: GND-01
Funding: $40M A Jan 2022

Drug notes:

About:

Jobs: